首页|基于贝叶斯网状meta分析中药治疗高尿酸血症及痛风的效果与安全性

基于贝叶斯网状meta分析中药治疗高尿酸血症及痛风的效果与安全性

扫码查看
目的 系统评价中药治疗高尿酸血症(HUA)及痛风的疗效与安全性的差异。方法 计算机检索中国知网(CNKI)、万方、CBM、PubMed等数据库,检索中药治疗高尿酸血症及痛风的随机对照试验(RCT),由2位研究员独立筛选文献并提取资料后应用ADDIS 16。1和Stata 15软件进行贝叶斯网状meta分析。结果 共有48篇文献符合纳入标准,包含4 674例受试患者,其中试验组患者2 431例,对照组患者2 236例,共涉及9种中药,13种用药方案,在提高总有效率方面,前三的治疗方案为:通滞苏润江胶囊>息痛散煎剂>四妙丸。在安全性方面,前三的治疗方案为:痛风宁>息痛散煎剂>痛风定胶囊。结论 与常规西药治疗对比,在提高总有效率方面,通滞苏润江胶囊效果最佳,在减少不良反应方面,痛风宁效果最佳,受纳入研究质量限制,此结论需更多高质量研究进行验证。
Efficacy and safety of traditional Chinese medicine in the treatment of hyperuricemia and gout based on Bayesian reticulum meta-analysis
Objective To evaluate the efficacy and safety of traditional Chinese medicine in the treatment of hyperuricemia(HUA)and gout.Methods CNKI,Wanfang,CBM,PubMed and other databases were searched for randomized controlled trials(RCTS)of Chinese medicine in the treatment of hyperuricemia and gout.After literature screening and data extraction by two researchers,ADDIS 16.1 and Stata 15 software were applied to perform Bayesian reticulum meta-analysis.Results A total of 48 literatures met the inclusion criteria,including 4 674 subjects,2 431 patients in the experimental group and 2 236 patients in the control group,involving a total of 9 traditional Chinese medicines,13 drug regiments.In terms of improving the total effective rate,the top three treatment regiments were:Tongzhi Surunjiang Capsules>Xitongsan Decoction>Simiao Pills.In terms of safety,the top three treatment plans are:Tongfengning>Xitongsan Decoction>Tongfengding Capsules.Conclusion Compared with conventional western medicine,Tongzhi Surunjiang Capsules has the best effect in improving the total effective rate,and Tongfengning has the best effect in reducing adverse reactions.Limited by the quality of included studies,this conclusion needs to be verified by more high-quality studies.

Traditional Chinese medicineHyperuricemiaGoutBayesian reticulum meta-analysis

丛新宇、高天舒

展开 >

辽宁中医药大学研究生学院,辽宁沈阳 110847

辽宁中医药大学附属医院内分泌科,辽宁沈阳 110032

中药 高尿酸血症 痛风 贝叶斯网状meta分析

辽宁省沈阳市临床医学研究中心项目

沈科发[2018]75号

2024

中国当代医药
中国保健协会 当代创新(北京)医药科学研究院

中国当代医药

影响因子:1.215
ISSN:1674-4721
年,卷(期):2024.31(7)
  • 57